Essra Ridha - Nov 1, 2021 Form 4 Insider Report for AVROBIO, Inc. (AVRO)

Role
Chief Medical Officer
Signature
/s/ Christopher Gerry, Attorney in Fact for Essra Ridha
Stock symbol
AVRO
Transactions as of
Nov 1, 2021
Transactions value $
$0
Form type
4
Date filed
11/2/2021, 04:59 PM
Previous filing
Oct 27, 2021
Next filing
Feb 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVRO Stock Option (Right to Buy) Award $0 +120K $0.00 120K Nov 1, 2021 Common Stock 120K $5.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares shall vest and become exercisable on November 1, 2022, and the remaining 75% shall vest in equal monthly installments thereafter over a 3 year period.